172 related articles for article (PubMed ID: 35762021)
21. Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism.
Wang K; Hu J; Yang J; Song Y; Fuller PJ; Hashimura H; He W; Feng Z; Cheng Q; Du Z; Wang Z; Ma L; Yang S; Li Q
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32449927
[TBL] [Abstract][Full Text] [Related]
22. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.
Song Y; Yang S; He W; Hu J; Cheng Q; Wang Y; Luo T; Ma L; Zhen Q; Zhang S; Mei M; Wang Z; Qing H; Bruemmer D; Peng B; Li Q;
Hypertension; 2018 Jan; 71(1):118-124. PubMed ID: 29158354
[TBL] [Abstract][Full Text] [Related]
23. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the oral fludrocortisone suppression test for diagnosing primary hyperaldosteronism in cats.
Djajadiningrat-Laanen SC; Galac ; Boevé MH; Boroffka SA; Naan EC; IJzer J; Kooistra HS
J Vet Intern Med; 2013; 27(6):1493-9. PubMed ID: 24627898
[TBL] [Abstract][Full Text] [Related]
25. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
Lin C; Yang J; Fuller PJ; Jing H; Song Y; He W; Du Z; Luo T; Cheng Q; Yang S; Wang H; Li Q; Hu J;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):131-137. PubMed ID: 31774187
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
27. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
28. Primary aldosteronism and hypertensive disease.
Mosso L; Carvajal C; González A; Barraza A; Avila F; Montero J; Huete A; Gederlini A; Fardella CE
Hypertension; 2003 Aug; 42(2):161-5. PubMed ID: 12796282
[TBL] [Abstract][Full Text] [Related]
29. Primary aldosteronism: rare bird or common cause of secondary hypertension?
Stowasser M
Curr Hypertens Rep; 2001 Jun; 3(3):230-9. PubMed ID: 11353574
[TBL] [Abstract][Full Text] [Related]
30. Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension.
Padfield PL; Allison ME; Brown JJ; Ferriss JB; Fraser R; Lever AF; Luke RG; Robertson JI
Clin Endocrinol (Oxf); 1975 Sep; 4(5):493-500. PubMed ID: 1175311
[TBL] [Abstract][Full Text] [Related]
31. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
[TBL] [Abstract][Full Text] [Related]
32. Serum aldosterone and cortisol concentrations before and after suppression with fludrocortisone in cats: a pilot study.
Matsuda M; Behrend EN; Kemppainen R; Refsal K; Johnson A; Lee H
J Vet Diagn Invest; 2015 May; 27(3):361-8. PubMed ID: 25901003
[TBL] [Abstract][Full Text] [Related]
33. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
[TBL] [Abstract][Full Text] [Related]
34. Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion.
Lucatello B; Benso A; Tabaro I; Capello E; Caprino MP; Marafetti L; Rossato D; Oleandri SE; Ghigo E; Maccario M
Eur J Endocrinol; 2013 Apr; 168(4):525-32. PubMed ID: 23321497
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
Lim PO; Dow E; Brennan G; Jung RT; MacDonald TM
J Hum Hypertens; 2000 May; 14(5):311-5. PubMed ID: 10822317
[TBL] [Abstract][Full Text] [Related]
36. [Update and Research Progress in the Diagnosis of Primary Aldosteronism].
Li YM; Ren Y; Chen T; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):267-277. PubMed ID: 32543129
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathological diversity of primary aldosteronism, including a new familial variety.
Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Finn WL; Krek AL
Clin Exp Pharmacol Physiol; 1991 May; 18(5):283-6. PubMed ID: 2065471
[TBL] [Abstract][Full Text] [Related]
38. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
Gordon RD; Ziesak MD; Tunny TJ; Stowasser M; Klemm SA
Clin Exp Pharmacol Physiol; 1993 May; 20(5):296-8. PubMed ID: 8324912
[TBL] [Abstract][Full Text] [Related]
39. Further evaluation of saline infusion for the diagnosis of primary aldosteronism.
Holland OB; Brown H; Kuhnert L; Fairchild C; Risk M; Gomez-Sanchez CE
Hypertension; 1984; 6(5):717-23. PubMed ID: 6389337
[TBL] [Abstract][Full Text] [Related]
40. Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism.
Jahan S; Yang J; Hu J; Li Q; Fuller PJ
Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38180077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
